NØCT is a nighttime nicotinamide riboside protocol, formulated to support NAD+ levels during the hours when cellular maintenance, DNA repair processes, and metabolic regulation are naturally active. No overstimulation. No hype. Just quiet, disciplined night science.
Clinically informed formulation. Third-party tested for identity, potency, and impurities.
Nicotinamide riboside
A clinically studied NAD+ precursor used in peer-reviewed human trials.
Night-aligned protocol
Designed to be taken in the evening, aligned with the body’s endogenous night repair cycles.
Measured, transparent
Clear labeling, conservative dosing, and no performance claims beyond NAD+ support.

Concept render. Final packaging may vary. Always follow the usage instructions on your specific lot.
Across disciplines—from chronobiology to metabolism research—night keeps showing up as a privileged window for cellular maintenance. Hormone patterns, DNA damage response, and metabolic signaling all shift when light goes down and sleep pressure increases.
NØCT is built around this basic fact: when biology behaves differently at night, support should be scheduled accordingly. Not to override your rhythms—but to respect and align with them.
Circadian context
Core body temperature, melatonin secretion, and cortisol all follow daily rhythms. NAD+-dependent enzymes are linked to these same clocks, creating time-of-day differences in how pathways are engaged.
Night and cellular upkeep
During consolidated sleep, the body prioritizes processes such as DNA damage response, autophagy, and synaptic remodeling. Many of these rely on NAD+-dependent enzymes as cofactors or regulators.
A calm-input philosophy
Night is when overstimulation is least welcome. NØCT avoids stimulants and aggressive stacks, focusing instead on a single, well-characterized NAD+ precursor in a restrained, evening-suitable protocol.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme involved in thousands of redox reactions. It sits at the core of pathways that convert nutrients into usable cellular energy and participates in signaling pathways related to DNA repair, gene expression, and metabolic regulation.
Research suggests that NAD+ levels can change with age and physiological stressors. Rather than trying to force outcomes, NØCT focuses on supplying a precursor molecule—nicotinamide riboside—that the body can convert into NAD+ through existing biochemical pathways.
What NØCT does not do
NØCT does not diagnose, treat, cure, or prevent any disease, and it does not promise specific performance outcomes. Its role is narrower and more respectful: to provide a characterized NAD+ precursor that can be integrated into a broader, clinician-guided approach to health.

Among various NAD+ precursors, nicotinamide riboside (NR) has been the focus of multiple peer-reviewed, placebo-controlled human studies examining its effects on NAD+ levels and related biomarkers. NØCT uses NR as its central active ingredient.
Characterization
NR has been evaluated in human studies for its ability to increase NAD+ levels, with dosing regimens typically ranging from several hundred to around 2000 mg per day in research settings. NØCT operates well within these explored ranges and adheres to conservative dosing principles.
Why not "more"?
Physiology rarely rewards excess. Rather than pursuing maximal dosing, NØCT prioritizes tolerability, consistency, and long-term integration with medical guidance when appropriate. The goal is compatibility with everyday life, not pharmacologic effect sizes.
Aligned with clinical thinking
NØCT is designed to be legible to physicians and researchers: a single primary active, transparent dose, known excipients, and documentation of third-party testing. This is supplementation intended to fit into evidence-based conversations—not circumvent them.
Evidence posture
Published NR trials have explored endpoints such as NAD+ levels and cardiometabolic markers. NØCT does not replicate these protocols and does not imply identical results; they simply inform our ingredient selection and safety perspective.
NØCT is deliberately minimal. Each component of the capsule and packaging system is chosen to reduce interference with sleep routines while maintaining stability, absorption, and reproducibility.
Suggested rhythm
NØCT is designed to be taken once daily in the early evening, ideally at a consistent time. Always follow the instructions on your product label and consult your healthcare provider before use.
With or without food
NR has been tolerated in studies taken with or without food. Individual responses can vary; many users prefer pairing NØCT with an evening meal to minimize any potential gastrointestinal discomfort.

NØCT is produced in facilities that follow current Good Manufacturing Practices (cGMP) for dietary supplements. Each lot is tested by independent laboratories for identity, potency, and a defined panel of potential contaminants.
Identity
Verification that the active ingredient is nicotinamide riboside and matches the specified form and purity standard.
Potency
Confirmation that the amount of NR per capsule is within tight tolerance of the label claim throughout shelf life.
Purity & contaminants
Screening for heavy metals, microbial contamination, and other predefined impurities according to internal specifications.
Documentation access
Batch-level Certificates of Analysis (COAs) are available to clinicians and partners upon request, subject to appropriate confidentiality protections.
NØCT is built as a system, not a single object: formulation, packaging, logistics, and disposal are considered as one continuous arc. The goal is not perfection, but transparent, incremental improvement with each production cycle.

Design notes
All sustainability claims are bounded by current supply chain realities. NØCT avoids vague promises such as "carbon neutral" and instead publishes specific, verifiable choices—materials, vendors, and incremental changes year over year.
NØCT is formulated and labeled as a dietary supplement, not a drug. All language, claims, and usage directions are developed to comply with U.S. dietary supplement regulations and to remain conservative where guidance is evolving.
Medical guidance
NØCT is not a substitute for medical care. Individuals who are pregnant, nursing, have underlying medical conditions, or are taking medications should consult a qualified healthcare professional before use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Designed for people who read methods sections. If you want a night-centered NAD+ support protocol that is restrained, transparent, and compatible with clinical oversight, NØCT was built for that use case.
Early access is limited and prioritized for individuals working with clinicians or research groups.
We do not sell or rent your data. Contact information is used solely to coordinate product availability and share technical updates about NØCT.
This page is intended for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making decisions about supplementation, medications, or lifestyle changes related to your health.
©
NØCT
A night-focused NAD+ support supplement built for people who value methods as much as outcomes.